Literature DB >> 10456233

Chronic effects of xanthines on levels of central receptors in mice.

D Shi1, J W Daly.   

Abstract

1. Chronic ingestion of caffeine causes a significant increase in levels of A1-adenosine, nicotinic and muscarinic receptors, serotonergic receptors, GABAA receptors and L-type calcium channels in cerebral cortical membranes from mice NIH Swiss strain mice. 2. Chronic theophylline and paraxanthine had effects similar to those of caffeine except that levels of L-type channels were unchanged. Chronic theobromine, a weak adenosine antagonist, and 1-isobutyl-3-methylxanthine (IBMX), a potent adenosine antagonist and phosphodiesterase inhibitor, caused only an increase in levels of A1-adenosine receptors. A combination of chronic caffeine and IBMX had the same effects on receptors as caffeine alone. Chronic 3,7-dimethyl-1-propargylxanthine (DMPX), a somewhat selective A2A-antagonist, caused only an increase in levels of A1-adenosine receptors. Pentoxifylline, an adenosine-uptake inhibitor inactive at adenosine receptors, had no effect on receptor levels or calcium channels. 3. A comparison of plasma and brain levels of xanthines indicated that caffeine penetrated more readily and attained somewhat higher brain levels than theophylline or theobromine. Penetration and levels were even lower for IBMX, paraxanthine, DMPX, and pentoxyfylline. 4. The results suggest that effective blockade of both A1 and A2A-adenosine receptors is necessary for the full spectrum of biochemical changes elicited by chronic ingestion of xanthines, such as caffeine, theophylline, and paraxanthine.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10456233     DOI: 10.1023/a:1006901005925

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  36 in total

1.  Chronic theophylline treatment increases adenosine A1, but not A2, receptor binding in the rat brain: an autoradiographic study.

Authors:  C R Lupica; R F Berman; M F Jarvis
Journal:  Synapse       Date:  1991-10       Impact factor: 2.562

2.  Up-regulation of brain [3H]diazepam binding sites in chronic caffeine-treated rats.

Authors:  P H Wu; V L Coffin
Journal:  Brain Res       Date:  1984-02-27       Impact factor: 3.252

3.  The xanthine derivative 1-(5'-oxohexyl)-3-methyl-7-propyl xanthine (HWA 285) enhances the actions of adenosine.

Authors:  B B Fredholm; K Lindström
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1986-03

4.  Adenosine actions and adenosine receptors after 1 week treatment with caffeine.

Authors:  B B Fredholm
Journal:  Acta Physiol Scand       Date:  1982-06

5.  Caffeine down-regulates beta adrenoreceptors in rat forebrain.

Authors:  M R Goldberg; P W Curatolo; C S Tung; D Robertson
Journal:  Neurosci Lett       Date:  1982-07-20       Impact factor: 3.046

6.  Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.

Authors:  B E Garrett; S G Holtzman
Journal:  Eur J Pharmacol       Date:  1994-09-01       Impact factor: 4.432

7.  Adenosine receptors and behavioral actions of methylxanthines.

Authors:  S H Snyder; J J Katims; Z Annau; R F Bruns; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1981-05       Impact factor: 11.205

8.  The effect of long term caffeine treatment on hypoxic-ischemic brain damage in the neonate.

Authors:  E Bona; U Adén; B B Fredholm; H Hagberg
Journal:  Pediatr Res       Date:  1995-09       Impact factor: 3.756

9.  Locomotor activity in mice during chronic treatment with caffeine and withdrawal.

Authors:  O Nikodijević; K A Jacobson; J W Daly
Journal:  Pharmacol Biochem Behav       Date:  1993-01       Impact factor: 3.533

10.  Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.

Authors:  D K Von Lubitz; I A Paul; X D Ji; M Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1994-02-21       Impact factor: 4.432

View more
  20 in total

Review 1.  Caffeine and the control of cerebral hemodynamics.

Authors:  Dale A Pelligrino; Hao-Liang Xu; Francesco Vetri
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  A comparison of the effects of caffeine following abstinence and normal caffeine use.

Authors:  Merideth A Addicott; Paul J Laurienti
Journal:  Psychopharmacology (Berl)       Date:  2009-09-24       Impact factor: 4.530

Review 3.  Exploring cocoa properties: is theobromine a cognitive modulator?

Authors:  Ilaria Cova; V Leta; C Mariani; L Pantoni; S Pomati
Journal:  Psychopharmacology (Berl)       Date:  2019-01-31       Impact factor: 4.530

4.  Psychopharmacology of theobromine in healthy volunteers.

Authors:  Matthew J Baggott; Emma Childs; Amy B Hart; Eveline de Bruin; Abraham A Palmer; Joy E Wilkinson; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2013-02-19       Impact factor: 4.530

5.  The effect of daily caffeine use on cerebral blood flow: How much caffeine can we tolerate?

Authors:  Merideth A Addicott; Lucie L Yang; Ann M Peiffer; Luke R Burnett; Jonathan H Burdette; Michael Y Chen; Satoru Hayasaka; Robert A Kraft; Joseph A Maldjian; Paul J Laurienti
Journal:  Hum Brain Mapp       Date:  2009-10       Impact factor: 5.038

Review 6.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

7.  Relationship between caffeine-induced changes in resting cerebral perfusion and blood oxygenation level-dependent signal.

Authors:  Paul J Laurienti; Aaron S Field; Jonathan H Burdette; Joseph A Maldjian; Yi-Fen Yen; Dixon M Moody
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

8.  Increases in cerebrospinal fluid caffeine concentration are associated with favorable outcome after severe traumatic brain injury in humans.

Authors:  Kathleen T Sachse; Edwin K Jackson; Stephen R Wisniewski; Delbert G Gillespie; Ava M Puccio; Robert S B Clark; C Edward Dixon; Patrick M Kochanek
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

9.  Regulation of cerebrospinal fluid production by caffeine consumption.

Authors:  Myoung-Eun Han; Hak-Jin Kim; Young-Suk Lee; Dong-Hyun Kim; Joo-Taek Choi; Chul-Sik Pan; Sik Yoon; Sun-Yong Baek; Bong-Seon Kim; Jae-Bong Kim; Sae-Ock Oh
Journal:  BMC Neurosci       Date:  2009-09-03       Impact factor: 3.288

10.  Systemic 7-methylxanthine in retarding axial eye growth and myopia progression: a 36-month pilot study.

Authors:  Klaus Trier; Søren Munk Ribel-Madsen; Dongmei Cui; Søren Brøgger Christensen
Journal:  J Ocul Biol Dis Infor       Date:  2008-11-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.